AT343932T
USE OF EXOGENOUS LACTIC BACTERIA STRAIN AGAINST i ACTINOMYCES NAESLUNDII /i RELATED DISEASES
Abstract
Around the oral cavity and biota of the exogenetic lactic acid strain; the preparation for reducing the mammalian dental plaque and treating or preventing the root decayed teeth and other with Neishi light fungi related diseases use of composition, wherein the lactic acid strain with an adhesive and inhibiting growth factor ability of the tooth cuticle.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
80 members in 30 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 00201948 | European Patent Office (EPO) | A |
Members80
| Document | Office | Kind | |
|---|---|---|---|
| CA2337082A1 | Canada | A1 | |
| WO0009080A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5415999A | Australia | A | |
| BR9912946A | Brazil | A | |
| MXPA01001038A | Mexico | A | |
| EP1104281A1 | European Patent Office (EPO) | A1 | |
| ID28917A | Indonesia | A | |
| KR20010072440A | Republic of Korea | A | |
| CN1312704A | China | A | |
| BG105188A | Bulgaria | A | |
| UY26748A1 | Uruguay | A1 | |
| EP1159951A1 | European Patent Office (EPO) | A1 | |
| CA2410591A1 | Canada | A1 | |
| WO0191711A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU7244901A | Australia | A | |
| TR2001000406T2 | Türkiye | T2 | |
| TR200100406T2 | Türkiye | T2 | |
| HU0103229A2 | Hungary | A2 | |
| HUP0103229A2 | Hungary | A2 | |
| PL345890A1 | Poland | A1 | |
| PE20011328A1 | Peru | A1 | |
| US2002012637A1 | United States of America | A1 | |
| ZA200101110B | South Africa | B | |
| IL140641A0 | Israel | A0 | |
| IL140641D0 | Israel | D0 | |
| AR020169A1 | Argentina | A1 | |
| JP2002522464A | Japan | A | |
| EP1296636A1 | European Patent Office (EPO) | A1 | |
| KR20030031490A | Republic of Korea | A | |
| MXPA02011973A | Mexico | A | |
| BR0111371A | Brazil | A | |
| AR028672A1 | Argentina | A1 | |
| NZ509722A | New Zealand | A | |
| IL153127A0 | Israel | A0 | |
| IL153127D0 | Israel | D0 | |
| HU0103229A3 | Hungary | A3 | |
| HUP0103229A3 | Hungary | A3 | |
| HU0301271A2 | Hungary | A2 | |
| HUP0301271A2 | Hungary | A2 | |
| NZ522911A | New Zealand | A | |
| TW552142B | Taiwan Province of China | B | |
| US2003170184A1 | United States of America | A1 | |
| CN1444469A | China | A | |
| JP2003534362A | Japan | A | |
| ZA200210308B | South Africa | B | |
| AU773799B2 | Australia | B2 | |
| PL360850A1 | Poland | A1 | |
| IN1972CH2002A | India | A | |
| IN156CH2001A | India | A | |
| US2005074416A1 | United States of America | A1 | |
| US2005186148A1 | United States of America | A1 | |
| US6942849B2 | United States of America | B2 | |
| AU2001272449B2 | Australia | B2 | |
| US2005238590A1 | United States of America | A1 | |
| CN1240372C | China | C | |
| CN1279890C | China | C | |
| EP1296636B1 | European Patent Office (EPO) | B1 | |
| AT343932TThis record | Austria | T | |
| ATE343932T1 | Austria | T1 | |
| RO121005B1 | Romania | B1 | |
| DE60124255D1 | Germany | D1 | |
| MX243373B | Mexico | B | |
| PT1296636E | Portugal | E | |
| KR20070035111A | Republic of Korea | A | |
| DE60124255T2 | Germany | T2 | |
| KR100727338B1 | Republic of Korea | B1 | |
| ES2275697T3 | Spain | T3 | |
| IL140641A | Israel | A | |
| US7491386B2 | United States of America | B2 | |
| PH12001001365B1 | Philippines | B1 | |
| PL201312B1 | Poland | B1 | |
| PL202576B1 | Poland | B1 | |
| JP4564169B2 | Japan | B2 | |
| MY142363A | Malaysia | A | |
| EP1104281B1 | European Patent Office (EPO) | B1 | |
| AT501640T | Austria | T | |
| ATE501640T1 | Austria | T1 | |
| DE69943283D1 | Germany | D1 | |
| ES2363201T3 | Spain | T3 | |
| CA2337082C | Canada | C |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 1951549
Titles2
- German
- VERWENDUNG VON EXOGENEN MILCHSÄUREBAKTERIEN ZUR BEHANDLUNG VON DURCH ACTINOMYCES NAESLUNDII HERVORGERUFENEN KRANKHEITEN
- English
- USE OF EXOGENOUS MILKY ACID BACTERIA FOR THE TREATMENT OF DISEASES CAUSED BY ACTINOMYCES NAESLUNDII
Classification
- CPC, 17
- A23G4/123
- A61K35/744
- A23C9/123
- A23C9/1236
- A23C9/1238
- A23C2220/206
- A23K10/18
- A23K40/30
- A23K50/40
- A23Y2240/75
- A61K8/99
- A61Q11/00
- A61P1/02
- Y10S435/822
- A61P31/00
- Y10S435/885
- A61P31/04
- IPC, 13
- A23L1 30
- A23C9 123
- A23G4 00
- A23G4 12
- A23K1 00
- A23K1 18
- A61K8 99
- A61K35 74
- A61K38 00
- A61P1 02
- A61P31 04
- A61Q11 00
- C12N1 20